Anthem Biosciences Limited Q4 FY26 results deck summary

Results deck of 19 May 2026, summarised by AI from the filing.

Anthem Biosciences Q4FY26 revenue ₹6,109 Mn, up 26.4% YoY, with EBITDA margin at 48.1% and PAT ₹1,898 Mn.

Key takeaways

1. Margin expansion Q4FY26 EBITDA margin expanded to 48.1% from 42.1% in Q4FY25, a 600 bps increase.
2. CRDMO growth CRDMO revenue grew 30.7% YoY in Q4FY26 to ₹5,128 Mn, driving overall revenue growth.
3. Labour Codes FY26 exceptional item of ₹243.91 Mn arose from Labour Codes; further Government clarification may require differential impact accounting.

Original filing on BSE

Anthem Biosciences Limited Q1 FY27 results

As filed: Revenue ₹418 cr (−23% year on year), EBITDA ₹151 cr (−21% year on year), PAT ₹120 cr (−12% year on year), EBITDA margin 36.0% (+63 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹583 cr, EBITDA ₹267 cr, PAT ₹212 cr, EBITDA margin 45.8%. Not scored. No result for the same quarter last year. Share price after the results: +1.4% in 30 days (Nifty 500: +3.0%).
• Q3 FY26: Revenue ₹417 cr, EBITDA ₹163 cr, PAT ₹112 cr, EBITDA margin 39.1%. Not scored. No result for the same quarter last year. Share price after the results: +21.1% in 30 days (Nifty 500: +2.8%).
• Q2 FY26: Revenue ₹552 cr, EBITDA ₹225 cr, PAT ₹198 cr, EBITDA margin 40.8%. Not scored. No result for the same quarter last year. Share price after the results: −6.8% in 30 days (Nifty 500: 0.0%).
• Q1 FY26: Revenue ₹538 cr, EBITDA ₹196 cr, PAT ₹148 cr, EBITDA margin 36.4%. Not scored. No result for the same quarter last year. Share price after the results: +10.4% in 30 days (Nifty 500: +2.2%).

Past price moves after results do not indicate future moves. Not a recommendation.

Anthem Biosciences Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (22 Jul 2026), Results deck (21 Jul 2026), Results deck (21 Jul 2026), Results press release (21 Jul 2026), Results press release (21 Jul 2026)
• Q4 FY26: Earnings call (20 May 2026), Results deck (19 May 2026)
• Q3 FY26: Earnings call (5 Feb 2026), Results deck (5 Feb 2026), Results press release (5 Feb 2026), Results press release (5 Feb 2026), Results press release (5 Feb 2026)
• Q2 FY26: Earnings call (10 Nov 2025), Results deck (8 Nov 2025), Results press release (8 Nov 2025)
• Q1 FY26: Earnings call (14 Aug 2025), Results deck (13 Aug 2025), Results press release (13 Aug 2025)